Unitinib 400 mg Capsule
$37.84
$22.95
Unitinib 400 mg capsules are a targeted anticancer therapy designed to combat specific types of leukemia and various blood-related cancers. This medication is particularly effective against gastrointestinal stromal tumors (GIST), which originate in the digestive tract's walls and may metastasize to other areas. Unitinib functions by inhibiting the growth signals of cancer cells, ultimately slowing tumor progression and improving patient outcomes. Additionally, it addresses protuberant tumors that cannot be surgically excised or have recurred post-surgery. While Unitinib offers significant therapeutic benefits, it's essential to be aware of potential side effects, including fatigue, gastrointestinal issues, and the risk of infection, necessitating regular monitoring by healthcare professionals. As a vital option in oncology, Unitinib empowers patients in their fight against cancer, contributing to a comprehensive treatment strategy. Always consult a healthcare provider to determine the appropriateness of this medication for individual health needs.
Quantity
Active Pharmaceutical Ingredient
Uses
• Unitinib 400 mg capsule is primarily indicated for the treatment of Chronic Myelogenous Leukemia (CML). This type of cancer impacts the blood-forming cells in the bone marrow. By targeting specific pathways involved in cancer cell growth, Unitinib helps to slow down the progression of the disease. Patients often experience improved outcomes when using this medication as part of their treatment plan.
• In addition to CML, Unitinib 400 mg capsule is also utilized in managing other conditions related to abnormal cell proliferation. Its mechanism of action focuses on inhibiting specific tyrosine kinases, which play a crucial role in tumor growth. This targeted approach can lead to better disease control and improved quality of life for patients. Healthcare providers may prescribe this medication based on individual patient profiles and treatment responses.
• Unitinib 400 mg capsule is frequently used in combination with other therapies to enhance treatment efficacy. This combination strategy may help to address resistance mechanisms that some patients face. By integrating Unitinib into a broader treatment regimen, clinicians aim to optimize patient outcomes. Regular monitoring and adjustments are essential to ensure the best possible therapeutic results.
• Patients receiving Unitinib 400 mg capsule typically benefit from ongoing assessments to evaluate treatment effectiveness. This medication is part of a comprehensive management plan that includes regular blood tests and clinical evaluations. Monitoring allows healthcare providers to tailor the treatment approach according to the patient's response. Overall, Unitinib serves as a valuable tool in the fight against CML and related disorders.
Benefits
Unitinib 400 mg Capsule helps to reduce the size of cancerous tumors and slow the growth of cancer cells.
Unitinib Capsule can be used as part of a treatment plan to help increase the chances of remission or cure in patients with certain types of cancer.
Unitinib 400 mg Capsule can help to reduce the number and severity of cancer-related symptoms, such as fatigue, pain, and nausea.
Unitinib 400 mg Capsule can be taken orally, which makes it easier for patients to take the medication, and Unitinib 400 mg Capsule has relatively few side effects compared to other cancer treatments, such as chemotherapy.
Side Effects
Adverse reactions may occur with the use of Unitinib 400 mg Capsule. Should you notice any of these side effects, it is advisable to consult your doctor or healthcare professional without delay. Your doctor can offer guidance on managing or alleviating these side effects.
Most Common Side Effects
• Nausea
• Vomiting
• Joint Pain
• Bone pain
• Muscle Cramps
• Sweating
• Watery Eyes
• Pink Eyes
• Flushing
• Itching
• Hair loss
Common Side Effects
• Shortness Of Breath
• Irregular Heartbeats
• Chest Pain
• Blistered skin
• Blood in Stool
• Severe Abdominal Pain and Bloating
• Blood in sputum
• High Fever
• Intestinal Bleeding
• Hepatic problems
• Diarrhea
• Dry mouth
• Loss of appetite
• Weight loss
• Headache
• Nail Color Changes
• Chills
• Sore throat
• Frequent Urination
• Tiredness
How To Use
Unitinib 400 mg can be taken with food or as directed by your doctor. It is best to take the same time daily to improve the clinical condition. If you miss a dose of Unitinib 400 mg Capsule take your next dose at your regularly scheduled time. The dose and duration of remedy will depend upon your condition. Do not stop taking this medicine without consulting your doctor.
Safety Advice
• Alcohol: The consumption of alcohol is generally not recommended when using Unitinib Capsule due to the increased risk of liver damage. It is best to either avoid alcohol altogether or limit its consumption while undergoing any medication.
• Kidney: Unitinib 400 mg Capsule should be used with mild kidney disease patients (CrCl 40 to <60 mL/min): Doses >600 mg/day are not recommended and moderate kidney patients (CrCl 20 to <40 mL/min). Decrease dose by 50%; may increase future doses if tolerated. Unitinib 400 mg Capsule used in caution patients with severe kidney disease take 100-mg/day dose was tolerated.
• Breastfeeding: The excretion of Unitinib Capsule in human milk is currently unknown. Considering that various drugs, including other anthracyclines, are excreted in human milk and the possibility of severe adverse reactions in nursing infants from Unitinib 400 mg Capsule, it is recommended that lactating women refrain from breastfeeding while undergoing treatment with Unitinib Capsule and for a minimum of 7 days after the final dose.
• Liver: Patients with liver disease should exercise caution when using Unitinib 400 mg Capsule. It is crucial for individuals with liver disease to closely observe their liver function while using Unitinib 400 mg Capsule and promptly inform their physician of any abnormal symptoms or changes in liver function. Adjustments to the dosage of Unitinib 400 mg Capsule may be necessary for patients with liver disease.
• Pregnancy: The use of Unitinib 400 mg Capsule during pregnancy may not be safe, as indicated by animal studies that suggest potential harm to the developing foetus. However, if you are currently pregnant or planning to become pregnant, it is crucial to consult your doctor about the potential risks and benefits of using Unitinib 400 mg Capsule during pregnancy. Your doctor will be able to assist you in making the most appropriate decision for the health and well-being of both you and your baby.
• Driving: Your doctor's instructions should be strictly followed, especially if you encounter any side effects from Unitinib 400 mg Capsule. These side effects, such as dizziness, fatigue, and difficulty concentrating and coordinating, have the potential to hinder your capability to drive a vehicle safely. Taking necessary precautions, such as refraining from driving or operating heavy machinery, is essential to ensure your well-being while using Unitinib Capsule.